Oxygen consumption in the heart, hepatomesenteric bed, and brain in young and elderly human subjects, and accompanying sympathetic nervous activity

Metabolism: Clinical and Experimental

Volumn 45, Issue 12, 1996, Pages 1487-1492

  Vaz, Mario ^a,b   Rajkumar, Chakravarthi ^a   Wong, James ^a   Mazzeo, Robert S ^a,c   Turner, Andrea G ^a   Cox, Helen S ^a   Jennings, Garry L ^a   Esler, Murray D ^a  

^a BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^b ST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES   (India)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NORADRENALIN;

ADULT; AGED; ARTICLE; BRAIN OXYGEN CONSUMPTION; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; HEART MUSCLE OXYGEN CONSUMPTION; HUMAN; HUMAN EXPERIMENT; ISOTOPE DILUTION ASSAY; MALE; MESENTERY BLOOD FLOW; NORMAL HUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SYMPATHETIC NERVE;

EID: 0030464951     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90177-8     Document Type: Article

References (50)

1. Poehlman ET, Horton ES: Regulation of energy expenditure in aging humans. Annu Rev Nutr 10:255-275, 1990
2. Poehlman ET, Berke EM, Joseph JR, et al: Influence of aerobic capacity, body composition, and thyroid hormones on the age-related decline in resting metabolic rate. Metabolism 41:915-921, 1992
3. Fukagawa NK, Bandini LG, Young JB: Effect of age on body composition and resting metabolic rate. Am J Physiol 259:E233-E238, 1990
4. Vaughan L, Zurlo F, Ravussin E: Aging and energy expenditure. Am J Clin Nutr 53:821-825, 1991
5. Pannemans DLE, Westerterp KR: Energy expenditure, physical activity and basal metabolic rate of elderly subjects. Br J Nutr 73:571-581, 1995
6. Poehlman ET, McAuliffe TL, Van Houten DR, et al: Influence of age and endurance training on metabolic rate and hormones in healthy men. Am J Physiol 259:E66-E72, 1990
7. Tzankoff SP, Norris AH: Effect of muscle mass decrease on age-related BMR changes. J Appl Physiol 43:1001-1006, 1977
8. Kurpad AV, Khan K, Calder AG, et al: Muscle and whole body metabolism after norepinephrine. Am J Physiol 266:E877-E884, 1994
9. WHO/FAO/UNU: Energy and protein requirements. Report of a joint FAO/WHO/UNU expert consultation. WHO Tech Rep Ser 724:43, 1985
10. Zurlo F, Larson K, Bogardus C, et al: Skeletal muscle metabolism is a major determinant of resting energy expenditure. J Clin Invest 86:1423-1427, 1990
11. Evers BM, Townsend CM, Thompson JC: Organ physiology of aging. Surg Clin North Am 74:23-39, 1994
12. Spraul M, Ravussin E, Fontvieille AM, et al: Reduced sympathetic nervous activity. A potential mechanism predisposing to body weight gain. J Clin Invest 92:1730-1735, 1993
13. Esler M, Skews H, Leonard P, et al: Age-dependence of norepinephrine kinetics in normal subjects. Clin Sci 60:217-219, 1981
14. Veith RC, Featherstone JA, Linares OA, et al: Age differences in plasma norepinephrine kinetics in humans. J Gerontol 41:319-324, 1986
15. Poehlman ET, McAuliffe T, Danforth E Jr: Effects of age and level of physical activity on plasma norepinephrine kinetics. Am J Physiol 258:E256-E262, 1990
16. Esler MD, Turner AG, Kaye DM, et al: Aging effects on human sympathetic neuronal function. Am J Physiol 268:R278-R285, 1995
17. Esler M, Jennings G, Lambert G, et al: Overflow of catecholamine neurotransmitters to the circulation: Source, fate, and functions. Physiol Rev 70:963-985, 1990
18. Esler M, Jackman G, Bobik A, et al: Determination of norepinephrine apparent release rate and clearance in humans. Life Sci 25:1461-1470, 1979
19. Cox HS, Kaye DM, Thompson JM, et al: Regional sympathetic nervous activation after a large meal in humans. Clin Sci 89:145-154, 1995
20. Vaz M, Cox HS, Kaye DM, et al: Fallibility of plasma norepinephrine measurements in studying postprandial sympathetic nervous responses. J Auton Nerv Syst 56:97-104, 1995
21. Esler M, Willett I, Leonard P, et al: Plasma norepinephrine kinetics in humans. J Auton Nerv Syst 11:125-144, 1984
22. Esler M, Jennings G, Korner P, et al: Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension 11:3-20, 1988
23. Esler M, Dudley F, Jennings G, et al: Increased sympathetic nervous activity and the effects of its inhibition with clonidine in alcoholic cirrhosis. Ann Intern Med 116:446-455, 1992
24. Vaz M, Turner A, Kingwell B, et al: Postprandial sympathoadrenal activity: Its relation to metabolic and cardiovascular events and to changes in meal frequency. Clin Sci 89:349-357, 1995
25. Devereux RB, Alonso DR, Lutas EM, et al: Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings. Am J Cardiol 57:450-458, 1986
26. Daly LE, Bourke GJ, McGilvray J: Interpretation and Uses of Medical Statistics (ed 4). London, UK, Blackwell Scientific, 1991, p 355
27. Camici P, Marraccini P, Marzilli M, et al: Coronary hemodynamics and myocardial metabolism during and after pacing stress in normal humans. Am J Physiol 257:E309-E317, 1989
28. Folkow B, Svanborg A: Physiology of cardiovascular aging. Physiol Rev 73:725-764, 1993
29. Olivetti G, Melissari M, Capasso JM, et al: Cardiomyopathy of the aging human heart: Myocyte loss and reactive cellular hypertrophy. Circ Res 68:1560-1568, 1991
30. Lie JT, Hammond PI: Pathology of the senescent heart: Anatomic observations on 237 autopsy studies of patients 90 to 105 years old. Mayo Clin Proc 63:552-564, 1988
31. Wei JY, Spurgeon HA, Lakatta EG: Excitation-contraction in rat myocardium: Alterations with adult aging. Am J Physiol 246:H784-H791, 1984
32. Wei JY, Li Y-X, Lincoln T, et al: Chronic exercise training protects aged cardiac muscle against hypoxia. J Clin Invest 83:778-784, 1989
33. Fabbri A, Marchesini G, Bianchi G, et al: Kinetics of hepatic amino-nitrogen conversion in ageing man. Liver 14:288-294, 1994
34. Marchesini G, Bua V, Brunori A, et al: Galactose elimination capacity and liver volume in aging man. Hepatology 8:1079-1083, 1988
35. Schnegg M, Lauterburg BH: Quantitative liver function in the elderly assessed by galactose elimination capacity, aminopyrine demethylation and caffeine clearance. J Hepatol 3:174-181, 1986
36. Goldman JE, Calinasan NY, Gibson GE: Aging and the brain. Curr Opin Neurol 7:287-293, 1994
37. Beal AF: Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 38:357-366, 1995
38. Sorbini CA, Grassi V, Solinas E: Arterial oxygen tension in relation to age in healthy subjects. Respiration 25:3-13, 1968
39. Wei JY: Age and the cardiovascular system. N Engl J Med 327:1735-1739, 1992
40. Esler MD, Thompson JM, Kaye DM, et al: Effects of aging oil the responsiveness of the human cardiac sympathetic nerves to Stressors. Circulation 91:351-358, 1995
41. Poehlman ET, Gardner AW, Goran MI, et al: Sympathetic nervous system activity, body fatness, and body fat distribution in younger and older males. J Appl Physiol 78:802-806, 1995
42. Hoeldtke RD, Cilmi KM: Effects of aging on catecholamine metabolism. J Clin Endocrinol Metab 60:479-484, 1985
43. White M, Roden R, Minobe W, et al: Age-related changes in β-adrenergic neuroeffector systems in the human heart. Circulation 90:1225-1238, 1994
44. Guaneri T, Filburn CR, Zitnik G, et al: Contractile and biochemical correlates of β-adrenergic stimulation of the aged human heart. Am J Physiol 239:H501-H508, 1980
45. Kety SS, Schmidt CF: The nitrous oxide method for quantitative determination of cerebral blood flow in man: Theory, procedure and normal values. J Clin Invest 27:476-483, 1948
46. 2 and cerebral hemodynamics. Am J Physiol 206:25-35, 1964
47. Shaw TG, Mortel KF, Sterling Myer J, et al: Cerebral blood flow changes in benign aging and cerebrovascular disease. Neurology 34:855-862, 1984
48. Pantano P, Baron J-C, Lebrun-Grandie P, et al: Regional cerebral blood flow and oxygen consumption in human aging. Stroke 15:635-641, 1984
49. 3H]norepinephrine in rat brain. J Neurochem 12:25-30, 1965
50. Aneman A, Eisenhofer G, Fandriks L, et al: Hepatomesenteric release and removal of norepinephrine in swine. Am J Physiol 268:R924-R930, 1995